Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03316378 · ClinicalTrials.gov registry record · Phase 2
Achilles Pain Block
A Phase 2 study, sponsored by Ruth Chimenti.
- Completed
- Registry status
- Phase 2
- Development phase
- 46
- Enrollment target
NCT03316378 is a Phase 2 study that has completed, run by Ruth Chimenti. The registered enrollment target is 46 participants.
The verdict
NCT03316378, a Phase 2 study, has completed, sponsored by Ruth Chimenti.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand how the peripheral and central nervous system interact to produce the sensation of pain and motor patterns in patients with achilles tendinopathy (AT). These findings will motivate the development of future clinical studies that incorporate knowledge about pain processing and movement strategies in patients with tendinopathy. Participants with achilles tendinopathy will receive an anesthetic injection to the achilles tendon in order to examine how reduced pain, detected by the peripheral nervous system, alters task performance and perception of pain. We hypothesize that there are factors within the central nervous system that contribute to continued pain and disability in patients with chronic AT.
Interventions
- DRUG Ropivacaine injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2016-01-28 |
| Est. Completion | 2018-05-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03316378
The ClinicalTrials.gov registry entry for NCT03316378 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ruth Chimenti, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ropivacaine injection is the first listed.
NCT03316378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03316378 about?
NCT03316378 is a clinical study titled "Achilles Pain Block". The purpose of this study is to better understand how the peripheral and central nervous system interact to produce the sensation of pain and motor patterns in patients with achilles tendinopathy (AT). These findings will motivate the development of future clinical studies that incorporate knowledge...
What is the current status of trial NCT03316378?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 2016-01-28. Estimated completion is 2018-05-10.
What interventions are being tested in trial NCT03316378?
The interventions under investigation include: Ropivacaine injection (DRUG).
Who is sponsoring clinical trial NCT03316378?
This trial is sponsored by Ruth Chimenti, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.